(Q46344148)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18820712%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

title

GVHD after chemotherapy conditioning in allogeneic transplanted mice (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18820712%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18820712%20AND%20SRC:MED&resulttype=core&format=json

Manuchehr Abedi-Valugerdi

14 January 2020

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18820712%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

author name string

N Aghdami

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18820712%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Z Hassan

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18820712%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

M Forouzanfar

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18820712%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

B Rozell

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18820712%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

M Hassan

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18820712%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

language of work or name

English

0 references

publication date

29 September 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18820712%20AND%20SRC:MED&resulttype=core&format=json

Bone Marrow Transplantation

14 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18820712%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

volume

42

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18820712%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18820712%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

page(s)

807-818

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18820712%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/bmt.2008.261

14 January 2020

exact match

0 references

cites work

Marrow Transplantation for Acute Nonlymphocytic Leukemia after Treatment with Busulfan and Cyclophosphamide

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.261

Graft-versus-host disease in experimental allogeneic bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.261

Naive and memory T cells induce different types of graft-versus-host disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.261

Stem cell transplantation: past, present and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.261

7 January 2021

Allogeneic hematopoietic stem cell transplantation--yesterday, today, and tomorrow

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.261

7 January 2021

Graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.261

7 January 2021

Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.261

7 January 2021

CCR2 is required for CD8-induced graft-versus-host disease.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.261

7 January 2021

The Pathophysiology of Acute Graft-versus-Host Disease

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.261

7 January 2021

Cytokines in graft-versus-host disease and the graft-versus-leukemia reaction

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.261

7 January 2021

Preparative regimens: chemotherapy versus chemoradiotherapy. A historical perspective

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.261

7 January 2021

Pharmacology of agents used in bone marrow transplant conditioning regimens

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.261

7 January 2021

https://api.crossref.org/works/10.1038%2FBMT.2008.261

1 reference

7 January 2021

Busulfan-cyclophosphamide versus total body irradiation-cyclophosphamide as preparative regimen before allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia: what have we learned?

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.261

7 January 2021

Long-term T cell fitness and proliferation is driven by AMPK-dependent regulation of reactive oxygen species

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.261

7 January 2021

Effect of altering administration order of busulphan and cyclophosphamide on the myeloablative and immunosuppressive properties of the conditioning regimen in mice

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.261

7 January 2021

Diagnosis of graft-versus-host disease in mice transplanted across minor histocompatibility barriers

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.261

7 January 2021

Bone marrow transplantation and approaches to avoid graft-versus-host disease (GVHD).

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.261

7 January 2021

L-selectin and beta7 integrin on donor CD4 T cells are required for the early migration to host mesenteric lymph nodes and acute colitis of graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.261

7 January 2021

Differences in MHC-class I presented minor histocompatibility antigens extracted from normal and graft-versus-host disease (GVHD) mice.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.261

7 January 2021

Cutaneous acute graft-versus-host disease to minor histocompatibility antigens in a murine model: histologic analysis and correlation to clinical disease

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.261

7 January 2021

Addition of treosulfan to a nonmyeloablative conditioning regimen results in enhanced chimerism and immunologic tolerance in an experimental allogeneic bone marrow transplant model

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.261

7 January 2021

A cautionary tale: how to delete mouse haemopoietic stem cells with busulphan

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.261

7 January 2021

The effect of modulation of glutathione cellular content on busulphan-induced cytotoxicity on hematopoietic cells in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.261

7 January 2021

Liposomal busulphan: bioavailability and effect on bone marrow in mice

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.261

7 January 2021

In vivo imaging of graft-versus-host-disease in mice.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.261

7 January 2021

Acute and chronic graft-versus-host disease induced by minor histocompatibility antigens in mice

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.261

7 January 2021

Lethal graft-versus-host disease after bone marrow transplantation across minor histocompatibility barriers in mice. Prevention by removing mature T cells from marrow

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.261

7 January 2021

Prevention of graft-versus-host disease by intra-bone marrow injection of donor T cells

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.261

7 January 2021

A two-phase pathogenesis of graft-versus-host disease in mice

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.261

7 January 2021

Skin biopsies for early diagnosis and prognosis of graft-versus-host disease in recipients of allogeneic stem cells from blood or bone marrow.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.261

7 January 2021

Acute graft-vs-host disease: pathobiology and management

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.261

7 January 2021

Experimental induction and ultrastructural characterization of apoptosis in murine acute cutaneous graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.261

7 January 2021

Tumor necrosis factor/cachectin is an effector of skin and gut lesions of the acute phase of graft-vs.-host disease

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.261

7 January 2021

Pathophysiology of acute graft-versus-host disease: recent advances

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.261

7 January 2021

Graft-versus-host disease of the skin: life and death on the epidermal edge.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.261

7 January 2021

Th1 and Th2 mediate acute graft-versus-host disease, each with distinct end-organ targets

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.261

7 January 2021

The role of cell-mediated cytotoxicity in acute GVHD after MHC-matched allogeneic bone marrow transplantation in mice

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.261

7 January 2021

In vivo analyses of early events in acute graft-versus-host disease reveal sequential infiltration of T-cell subsets

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.261

7 January 2021

Prevention of graft versus host disease by inactivation of host antigen-presenting cells

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.261

7 January 2021

Peyer's patch is the essential site in initiating murine acute and lethal graft-versus-host reaction

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.261

7 January 2021

Gut injury in mouse graft-versus-host reaction. Study of its occurrence and mechanisms

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.261

7 January 2021

Graft-versus-host disease in the absence of the spleen after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.261

7 January 2021

T cell subsets and graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.261

7 January 2021

Properties of purified T cell subsets. II. In vivo responses to class I vs. class II H-2 differences

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.261

7 January 2021

Erythropoietin for the treatment of porphyria cutanea tarda in a patient on long-term hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.261

7 January 2021

Progression from acute to chronic disease in a murine parent-into-F1 model of graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.261

7 January 2021

Factors influencing B lymphopoiesis after allogeneic hematopoietic cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.261

7 January 2021